Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Cancer Prevention02:59

Cancer Prevention

8.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.6K
Primary Healthcare Services01:30

Primary Healthcare Services

2.6K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
2.6K
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

15.3K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
15.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Diel Activity Patterns of Bobcats and Domestic Cats in the Houston Metropolitan Area.

microPublication biology·2026
Same author

Beyond the Surface: Duodenal-Type Follicular Lymphoma Diagnosed Despite Normal-Appearing Duodenal Mucosa and Absence of Focal Duodenal FDG Uptake.

Case reports in gastrointestinal medicine·2026
Same author

Devices and approaches for leaflet modification.

JTCVS structural and endovascular·2026
Same author

Correction: Heart Disease in Older Women: Unique Challenges in Diagnosis and Management.

Current cardiology reports·2026
Same author

Diagnostic Performance of Two CCTA Derived Noninvasive FFR Techniques: The TripleFFR Study.

Circulation. Cardiovascular imaging·2026
Same author

Heart Disease in Older Women: Unique Challenges in Diagnosis and Management.

Current cardiology reports·2026

相关实验视频

Updated: Mar 7, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K

使用"从9岁开始"策略增加HPV疫苗接种率:一个试点计划.

Sarah Malik1, Sarah Gu1, Jaclyn Sisskind1

  • 1Department of Pediatrics, SUNY Upstate Medical University, Syracuse, NY, United States of America.

Vaccine
|March 5, 2026
PubMed
概括

在9岁时推人乳头瘤病毒 (HPV) 疫苗显著提高了到13岁时及时完成疫苗接种率. 这种多层次的计划在儿科实践中被证明是可行的和有效的.

科学领域:

  • 预防儿童传染病的预防.
  • 疫苗接种和免疫策略.
  • 公共卫生干预措施 公共卫生干预

背景情况:

  • 到13岁的人类乳头瘤病毒 (HPV) 疫苗完成率仍然低于最佳水平.
  • 早些时候开始HPV疫苗接种可能会改善及时完成.
  • 目前的战略需要加强以实现公共卫生目标.

研究的目的:

  • 评估建议在9岁时接种HPV疫苗对完成疫苗接种率的影响.
  • 评估实施早期HPV疫苗接种多层次干预计划的可行性.
  • 分析影响儿科环境中HPV疫苗接种的因素.

主要方法:

  • 在两个儿科实践中实施一个多层次计划,包括政策变化,提供者教育和EHR修改.
  • 月度图表审查和季度收集关于9-12岁儿童的HPV疫苗接种状态和人口统计数据.
  • 在计划实施之前和之后,对HPV疫苗接种率和记录率的分析.

主要成果:

  • 在9-10岁儿童中,HPV疫苗的中位数从8%增加到41% (城市) 和3%增加到23% (郊区).
  • 在这两种实践中,9-12岁儿童的HPV疫苗完成率显著增加 (p < 0.001).
  • 在提供者推文档和HPV疫苗接种之间观察到强烈的相关性.
关键词:
青少年疫苗 青少年疫苗在HPV中,HPV是HPV.疫苗接种率是如何实现的

更多相关视频

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.4K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.4K

相关实验视频

Last Updated: Mar 7, 2026

Use of Interferon-&#947; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.4K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.4K

结论:

  • 一个多层次的计划建议9岁的HPV疫苗是可行的和有效的.
  • 早期的HPV疫苗推提高了13岁之前的完成率.
  • 这一干预表明了提高儿童免疫覆盖率的成功策略.